# A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

> **NCT01752959** · PHASE4 · UNKNOWN · sponsor: **Diskapi Teaching and Research Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Deviation Septum Nasal

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT01752959
- **Lead sponsor:** Diskapi Teaching and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752959, "A Comparison of Esmolol and Remifentanil to Reduce Blood Loss". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01752959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*